past
decad
field
innat
immun
assum
greater
import
role
earli
phase
immun
respons
pathogen
result
term
becom
somewhat
restrict
mean
refer
event
associ
initi
recognit
respons
pathogen
antigen
nonspecif
cell
molecul
immun
system
howev
innat
nonspecif
defens
infecti
agent
much
older
histori
exocrin
secret
bodi
contain
mani
highli
divers
humor
ie
solubl
factor
protect
bodi
major
potenti
pathogen
enter
along
food
air
intim
contact
individu
princip
subject
chapter
contribut
innat
defens
factor
protect
mucos
surfac
microbi
colon
aggress
probabl
greatli
underestim
evid
seen
igadefici
subject
lack
siga
antibodi
secret
yet
sever
compromis
even
though
defici
may
partial
compens
secretori
igm
small
amount
igg
secret
see
chapter
furthermor
innat
defens
mechan
help
defin
minim
requir
success
colon
commens
pathogen
organ
adapt
condit
incap
maintain
within
host
much
earlier
work
innat
defens
system
mucos
secret
perform
saliva
milk
readili
access
larg
quantiti
howev
becom
appar
similar
mechan
oper
secret
although
signific
differ
detail
increas
attent
antimicrobi
factor
present
genit
tract
occas
acquir
immun
defici
syndrom
aid
epidem
exampl
reveal
tract
multipl
nonimmunoglobulinbas
defens
mechan
quayl
import
note
mucos
surfac
first
present
mechan
barrier
consist
epithelium
vari
singl
columnar
cell
layer
gastrointestin
respiratori
tract
stratifi
sometim
keratin
epithelium
mouth
lower
femal
genit
tract
vagina
surfac
reinforc
copiou
secret
mucu
propel
peristalt
ciliari
action
thought
physic
entrap
microparticl
includ
microorgan
howev
specif
interact
mucin
bacteri
receptor
may
also
involv
lichtman
et
al
see
also
chapter
furthermor
mucos
surfac
desquam
consider
turnov
epitheli
cell
estim
per
day
human
small
intestin
alon
potten
morri
shed
carri
burden
attach
microorgan
sensit
immunochem
assay
usual
reveal
presenc
complement
protein
especi
major
compon
variou
secret
furthermor
epitheli
cell
found
synthes
complement
compon
factor
b
strunk
et
al
howev
concentr
complement
compon
present
usual
well
found
serum
consequ
uncertain
whether
classic
altern
complement
pathway
oper
fulli
function
system
secret
phagocyt
repres
major
compon
innat
defens
cellular
level
class
phagocyt
includ
macrophag
neutrophil
eosinophil
mast
cell
occur
within
mucos
tissu
develop
special
characterist
accord
locat
exampl
mucos
mast
cell
chapter
lamina
propria
macrophag
chapter
although
activ
phagocyt
may
larg
confin
tissu
least
normal
healthi
circumst
rather
take
place
within
lumen
microenviron
close
mucos
surfac
may
permit
phagocyt
activ
case
alveolar
macrophag
secret
hypoton
phagocyt
probabl
surviv
function
activ
long
bulk
fluid
phase
howev
content
may
releas
upon
lysi
surfac
degranul
therebi
contribut
solubl
antimicrobi
factor
secret
part
lactoferrin
lysozym
well
myeloperoxidas
distinct
salivari
peroxidas
found
whole
saliva
milk
exampl
origin
neutrophil
emigr
gingiv
crevic
lactat
mammari
gland
moldoveanu
et
al
milk
howev
isoton
contain
variabl
number
macrophag
neutrophil
depend
upon
stage
lactat
exogen
endogen
stimuli
huge
number
neutrophil
accumul
rapidli
milk
respons
infect
mastiti
phagocyt
activ
compromis
constitu
milk
particularli
casein
ingest
competit
microorgan
result
prematur
activ
divers
attenu
neutrophil
intracellular
kill
mechan
grazioso
buescher
innat
immun
recognit
mediat
seri
germlineencod
receptor
known
patternrecognit
receptor
prr
detect
virul
microorgan
recognit
invari
pathogenassoci
molecular
pattern
pamp
akira
particular
import
prr
involv
lipopolysaccharid
lp
recognit
subsequ
activ
signal
event
molecul
includ
lpsbind
protein
lbp
integrin
tolllik
receptor
tlr
akira
studi
wildtyp
prrdefici
mice
well
human
macrophag
activ
lp
taxol
bacteri
fimbria
suggest
tlr
integrin
form
function
multireceptor
complex
coordin
induct
intracellular
signal
perera
et
al
hajisheng
et
al
tlr
constitut
evolutionarili
conserv
prr
famili
serv
central
signaltransduc
element
induct
immunoregulatori
gene
trigger
innat
immun
instruct
develop
adapt
immun
induc
regulatori
proinflammatori
molecul
includ
cytokin
chemokin
cellular
adhes
molecul
costimulatori
molecul
surprisingli
tlr
express
mainli
cell
mediat
firstlin
defens
neutrophil
monocyt
macrophag
dendrit
cell
mucos
epitheli
cell
cario
podolski
zaremb
godowski
prr
like
play
import
role
mucos
defens
cell
surfac
receptor
also
humor
factor
inde
least
prr
natur
found
solubl
form
may
contributori
regulatori
effect
function
cellassoci
version
classic
exampl
glycoprotein
attach
cell
membran
mean
glycosylphosphatidylinositol
gpi
anchor
therefor
devoid
cytoplasm
domain
haziot
et
al
addit
membran
form
molecul
also
found
two
solubl
form
one
proteolyt
liber
gpi
anchor
second
escap
cell
membran
bufler
et
al
haziot
et
al
found
serum
biolog
fluid
milk
cerebrospin
fluid
urin
bussolati
et
al
et
al
landmann
et
al
like
also
bind
lp
result
complex
activ
mucos
epitheli
cell
express
pugin
et
al
activ
signal
transduc
tlr
akira
milkderiv
may
facilit
neonat
intestin
epitheli
cell
respons
lp
et
al
convers
injuri
may
induc
lp
renal
tubular
epitheli
cell
lead
proteinuria
bussolati
et
al
contrast
agonist
activ
cell
high
level
may
inhibit
lpsinduc
releas
monocytesmacrophag
compet
lp
haziot
et
al
level
upregul
sepsi
landmann
et
al
possibl
mitig
sever
diseas
sinc
lp
lethal
mice
diminish
recombin
haziot
et
al
lpsbind
protein
acutephas
protein
transfer
lp
monom
micel
result
cell
activ
aggreg
complex
highdens
lipoprotein
hdl
result
lp
neutral
akira
thu
low
lbp
concentr
may
enhanc
biolog
activ
lp
wherea
acut
phase
high
concentr
may
inhibitori
suggest
protect
effect
lbp
endotoxin
shock
mice
lamp
et
al
although
solubl
form
human
tlr
report
altern
splice
murin
mrna
describ
result
express
secretori
form
devoid
transmembran
intracellular
domain
iwami
et
al
function
inhibit
lpsinduc
activ
releas
humor
prr
also
report
suppress
inflammatori
function
membran
prr
pulmonari
surfact
protein
spa
inhibit
staphylococcu
aureu
peptidoglycaninduc
releas
human
monocyt
cell
rat
alveolar
macrophag
bind
directli
murakami
et
al
spa
also
engag
prevent
cellular
activ
respons
certain
serotyp
lp
sano
et
al
solubl
prr
therefor
allow
innat
immun
system
regul
cellular
activ
posit
negativelyth
properti
solubl
prr
mediat
agonist
antagonist
effect
render
attract
tool
manipul
innat
immun
system
instruct
role
develop
adapt
immun
exampl
identif
applic
prr
recognit
domain
act
decoy
receptor
may
help
develop
novel
strategi
aim
downregul
immun
respons
variou
chronic
inflammatori
diseas
sinc
initi
discoveri
lysozym
tear
nasal
secret
alexand
fleme
huge
literatur
accumul
structur
function
genet
biosynthesi
regul
enzym
activ
properti
reader
refer
definit
monograph
summar
much
inform
enzymat
lysozym
muramidas
ec
hydrolyz
glycosid
bond
nacetylmuram
acid
nacetyldglucosamin
bacteri
peptidoglycan
chipman
sharon
convent
type
c
lysozym
identifi
wide
mammal
bird
reptil
even
insect
form
lysozym
c
bind
calcium
differ
enzym
design
lysozym
g
found
bird
enzym
similar
activ
occur
plant
bacteriophag
lysozym
c
first
enzym
sequenc
resolv
xray
crystallographi
mechan
action
propos
ident
form
lysozym
c
occur
variou
human
bodi
fluid
tissu
abund
specif
granul
neutrophilsth
concentr
lysozym
differ
secret
vari
wide
tabl
concentr
also
differ
markedli
speci
exampl
human
milk
contain
approxim
time
higher
level
lysozym
cow
milk
chandan
et
al
lysozym
within
given
fluid
may
origin
differ
sourc
exampl
human
saliva
lysozym
produc
salivari
gland
oral
phagocyt
deriv
gingiv
crevic
korsrud
brandtzaeg
moro
et
al
lysozym
consist
singl
polypeptid
chain
amino
acid
residu
human
enzym
contain
residu
r
pi
four
disulfid
bridg
stabil
molecul
compact
ellipsoid
shape
review
see
crystallograph
structur
fig
reveal
two
domain
one
domain
compris
ntermin
ctermin
segment
smaller
domain
review
see
strynadka
jame
highli
conserv
activ
site
genet
type
c
lysozym
encod
rel
small
gene
four
exon
three
intron
irwin
et
al
although
lysozym
isol
differ
speci
even
differ
tissu
speci
show
similar
biolog
activ
differ
biochem
specif
activ
human
lysozym
higher
specif
activ
potent
antibacteri
effect
oral
microorgan
hen
eggwhit
lysozym
iacono
et
al
howev
speci
bacteria
directli
lyse
lysozym
mode
action
independ
enzymat
activ
describ
includ
activ
bacteri
autolysin
bacteri
aggreg
block
bacteri
adher
inhibit
acid
product
oral
microorgan
iacono
et
al
laibl
germain
twetman
et
al
wang
germain
moreov
cell
wall
oral
streptococci
weaken
cleavag
peptidoglycan
becom
suscept
lysi
addit
deterg
monoval
anion
bicarbon
fluorid
thiocyan
chlorid
predomin
saliva
pollock
et
al
treat
high
concentr
lysozym
absenc
salt
deterg
streptococcu
chapter
innat
humor
defens
factor
mutan
exhibit
area
cell
wall
dissolut
without
cell
lysi
cho
et
al
cation
properti
pi
may
allow
lysozym
exert
bactericid
activ
analog
cation
protein
although
bind
oral
bacteria
strongli
depend
ph
ionic
strength
bacteriolysi
caus
lysozym
may
physiolog
signific
oral
environ
paramet
fluctuat
markedli
howev
clear
evid
salivari
level
lysozym
relat
occurr
dental
cari
periodont
diseas
tenovuo
remark
lysozym
report
display
inhibitori
activ
human
immunodefici
sever
synergist
effect
lysozym
nonimmunoglobulin
immunoglobulin
defens
factor
report
includ
bactericid
effect
mutan
exert
lysozym
irondeplet
lactoferrin
soukka
et
al
inhibit
glucos
uptak
oral
streptococci
lysozym
compon
salivari
peroxidaseh
scn
system
includ
oxid
product
hypothiocyanit
lenanderlumikari
et
al
possibl
membran
damag
caus
cation
natur
lysozym
facilit
diffus
thiocyan
oxid
product
cell
lysozym
report
synerg
also
secretori
iga
siga
antibodi
complement
caus
lysi
escherichia
coli
report
confirm
studi
possibl
contamin
factor
contribut
effect
observ
lysozym
display
sequenc
homolog
abund
protein
milk
togeth
galactosyltransferas
form
lactos
synthas
thought
evolv
calciumbind
lysozym
c
diverg
bird
mammal
retain
conserv
calciumbind
residu
found
lysozym
c
mckenzi
white
although
normal
devoid
muramidas
antibacteri
activ
variant
form
report
induc
apoptosi
tumor
cell
variant
design
hamlet
human
made
lethal
tumor
cell
found
oligomer
molten
globul
conform
could
induc
releas
calcium
low
ph
presenc
oleic
acid
condit
may
occur
nurs
infant
stomach
author
specul
hamlet
could
serv
protect
infant
gut
form
also
report
bactericid
streptococcu
pneumonia
et
al
lactoferrin
member
transferrin
famili
ironbind
protein
like
plasma
transferrin
lactoferrin
revers
bind
two
ferric
ion
unlik
transferrin
primarili
protein
exocrin
secret
tabl
neutrophil
granul
clearli
defin
role
iron
transport
metabol
nevertheless
plethora
function
propos
lactoferrin
despit
much
research
still
consensu
import
vivo
mani
propos
function
lactoferrin
relat
antimicrobi
antiinflammatori
immunomodulatori
activ
discuss
chapter
other
possibl
role
iron
absorpt
neonat
develop
fall
outsid
scope
book
dealt
comprehens
review
aspect
lactoferrin
structur
function
see
schryver
vogel
lactoferrin
synthes
varieti
mucos
tissu
major
site
mammari
gland
genit
tract
review
teng
concentr
vari
differ
tissu
differ
speci
inde
mammal
eg
rat
rabbit
contain
lactoferrin
milk
masson
hereman
major
sourc
lactoferrin
secondari
granul
neutrophil
lactoferrin
synthes
myeloid
precursor
rather
matur
neutrophil
rado
et
al
signific
synthesi
also
occur
kidney
minim
synthesi
occur
liver
spleen
teng
lactoferrin
number
speci
identifi
character
structur
like
member
transferrin
famili
singlechain
glycoprotein
molecular
weight
kda
lactoferrin
typic
show
sequenc
homolog
serum
transferrin
baker
polypeptid
chain
fold
two
lobe
show
sequenc
homolog
indic
ancestr
gene
duplic
fig
lobe
turn
fold
two
domain
separ
cleft
ironbind
site
locat
case
ferric
iron
ligand
aspart
acid
two
tyrosin
histidin
togeth
two
oxygen
atom
synergist
bound
carbon
ion
without
lactoferrin
bind
iron
baker
iron
bind
releas
associ
conform
chang
protein
lactoferrin
ironfre
apo
form
interdomain
cleft
adopt
open
configur
bind
iron
carbon
caus
cleft
close
becom
lock
configur
anderson
et
al
one
consequ
open
apo
form
suscept
denatur
proteolyt
digest
febound
holo
form
iron
releas
lower
ph
lactoferrin
degre
stabil
lobe
structur
greater
transferrin
consequ
iron
releas
occur
ph
reach
wherea
transferrin
iron
releas
occur
ph
mazuri
spik
probabl
explain
transferrin
lactoferrin
donat
iron
cell
via
receptormedi
endocytosi
anoth
import
structur
differ
lactoferrin
transferrin
wherea
transferrin
pi
around
hovanessian
awdeh
lactoferrin
highli
basic
protein
pi
moguilevski
et
al
presenc
sever
surfac
region
high
posit
charg
notabl
near
nterminu
molecul
case
human
lactoferrin
four
consecut
arginin
posit
high
pi
lactoferrin
make
extrem
sticki
protein
result
bind
readili
macromolecul
lampreav
et
al
probabl
enabl
adher
mucos
surfac
sticki
lactoferrin
also
hamper
attempt
character
true
lactoferrin
receptor
lactoferrinbind
site
affin
compar
exhibit
specif
receptor
identifi
hepatocyt
mcabe
esbensen
monocyt
macrophag
birgen
et
al
activ
lymphocyt
mazuri
et
al
mammari
epitheli
cell
rochard
et
al
intestin
brush
border
cell
howev
enterocyt
brush
border
receptor
far
clone
function
express
suzuki
et
al
probabl
mani
receptor
interact
basic
ntermin
region
lactoferrin
el
yazidibelkoura
et
al
particular
interest
report
activ
cell
express
lactoferrin
receptor
show
enhanc
vitro
prolifer
presenc
lactoferrin
minchevanilsson
et
al
consequ
lactoferrincel
interact
gener
poorli
understood
interact
hepatocyt
lead
intern
degrad
lactoferrin
mcabe
et
al
intern
lymphocyt
also
report
bi
et
al
howev
monocyt
show
appreci
intern
bound
lactoferrin
ismail
brock
interact
lactoferrin
lymphocyt
result
mitogenactiv
protein
nlobe
left
clobe
right
lobe
bound
iron
atom
shown
black
sphere
center
associ
carbon
ion
antibacteri
domain
surfac
nlobe
highlight
black
nterminu
cluster
posit
charg
residu
found
label
n
cell
signal
event
trigger
lactoferrinreceptor
interact
despit
larg
number
studi
lactoferrin
function
clearli
defin
role
lactoferrin
yet
emerg
unlik
transferrin
good
evid
play
major
role
iron
transport
lactoferrin
enhanc
iron
absorpt
gut
hernel
lonnerd
inde
lactoferrin
knockout
mice
show
abnorm
iron
statu
ward
et
al
propos
function
base
predominantli
vitro
studi
mani
case
mechan
involv
unknown
case
known
activ
usual
attribut
either
lactoferrin
ironbind
properti
basic
particular
peptid
contain
basic
ntermin
region
lactoferrin
lactoferricin
isol
shown
activ
intact
protein
lactoferrin
report
inhibit
growth
reduc
infect
wide
rang
infecti
agent
includ
bacteria
virus
variou
parasit
mani
differ
organ
mechan
implic
follow
discuss
particular
attent
given
potenti
mucos
pathogen
one
first
function
attribut
lactoferrin
bacteriostat
activ
follow
demonstr
lactoferrin
could
inhibit
growth
variou
bacteria
vitro
activ
shown
apolactoferrin
addit
iron
abolish
activ
indic
inhibit
microbi
iron
uptak
involv
larg
rang
microorgan
suscept
activ
includ
mucos
pathogen
enteropathogen
e
coli
salmonella
spp
vibrio
cholera
field
extens
review
weinberg
howev
mani
bacteria
overcom
bacteriostat
effect
ironwithhold
lactoferrin
secret
lowmolecularweight
highaffin
iron
chelat
siderophor
remov
iron
lactoferrin
possibl
scaveng
iron
host
sourc
brock
et
al
other
notabl
haemophilu
spp
meningococci
express
specif
lactoferrin
receptor
regul
bacteri
iron
level
allow
organ
acquir
lactoferrinbound
iron
grayowen
schryver
inhibit
growth
may
consequ
iron
withhold
lactoferrin
case
pseudomona
aeruginosa
lack
iron
prevent
organ
form
biofilm
thu
make
suscept
host
defens
mechan
singh
et
al
contrast
felactoferrin
could
inhibit
bind
actinobacillu
actinomycetemcomitan
buccal
epitheli
cell
wherea
apolactoferrin
ineffect
fine
furgang
suggest
low
iron
level
might
actual
aid
colon
howev
iron
withhold
may
mechan
lactoferrin
inhibit
bacteria
bactericid
effect
independ
ironbind
activ
first
demonstr
arnold
et
al
subsequ
investig
show
involv
increas
membran
permeabl
ellison
giehl
mediat
basic
ntermin
region
lactoferrin
isol
lactoferricin
peptid
activ
intact
lactoferrin
bellami
et
al
effect
case
abrog
bacteri
proteas
presum
digest
lactoferricin
peptid
ulvatn
et
al
bacteri
molecul
lactoferrin
peptid
bind
vari
aureu
bind
cell
wall
teichoic
acid
vorland
et
al
wherea
e
coli
lipopolysaccharid
vorland
et
al
porin
sallmann
et
al
pneumonia
lactoferrin
bind
pneumococc
surfac
protein
hammerschmidt
et
al
gardnerella
vaginali
surfac
protein
respons
jarosik
land
though
may
analog
ironregul
receptor
mention
previous
novel
antibacteri
activ
lactoferrin
demonstr
inactiv
two
colon
factor
proteas
hap
adhesin
haemophilu
influenza
result
intrins
serin
proteas
activ
hendrixson
et
al
suggest
lactoferrin
truli
bifunct
protein
possibl
activ
might
caus
contamin
milk
proteas
bound
lactoferrin
seem
rule
milk
recombin
human
lactoferrin
activ
rather
similar
model
lactoferrin
bound
caus
proteolyt
cleavag
hemoglobin
receptor
porphyromona
gingivali
thu
prevent
organ
obtain
hemoglobinbound
iron
shi
et
al
howev
case
proteolyt
activ
may
origin
bacterium
lactoferricin
peptid
also
activ
yet
contain
region
thought
respons
serin
proteas
activ
lactoferrin
hendrixson
et
al
although
antibacteri
effect
lactoferrin
ampli
confirm
vitro
evid
vivo
activ
especi
clinic
data
less
convinc
fact
lactoferrin
occur
high
concentr
human
milk
breastf
babi
less
suscept
bottlef
babi
gastrointestin
infect
suggest
lactoferrin
might
import
protect
factor
breast
milk
attempt
modifi
gastrointestin
flora
newborn
bottlef
infant
supplement
formula
milk
lactoferrin
fail
demonstr
role
robert
et
al
howev
evid
lactoferrin
protect
bacteri
infect
anim
model
experiment
helicobact
infect
amelior
oral
administr
lactoferrin
wang
et
al
appear
result
glycan
moieti
lactoferrin
interf
bacteri
adher
rather
iron
depriv
colon
kidney
murin
aureu
infect
reduc
either
system
oral
administr
lactoferrin
bhimani
et
al
joint
inflamm
experiment
murin
aureu
infecti
arthriti
reduc
local
administr
lactoferrin
guillen
et
al
oral
administr
lactoferrin
lactoferricin
peptid
also
reduc
overgrowth
transloc
enterobacteria
occur
mice
fed
bovin
milk
teraguchi
et
al
oral
recombin
human
lactoferrin
reduc
sever
system
e
coli
infect
neonat
rat
infect
oral
rout
edd
et
al
also
shown
lactoferrin
could
protect
rabbit
experiment
shigella
flexneri
infect
mechan
involv
inhibit
basic
ntermin
region
lactoferrin
bacteri
uptak
host
cell
gomez
et
al
interest
antibacteri
effect
lactoferrin
clearli
depend
upon
ironbind
properti
report
schaibl
et
al
show
microglobulinknockout
mice
suffer
iron
overload
condit
similar
human
hemochromatosi
becam
less
suscept
tuberculosi
follow
treatment
lactoferrin
studi
experiment
anim
suggest
lactoferrin
might
therapeut
effect
certain
type
bacteri
infect
man
hope
appropri
clinic
studi
devis
lactoferrin
report
prevent
infect
varieti
virus
review
see
van
der
strate
et
al
dna
rna
virus
suscept
includ
cytomegaloviru
hiv
herpesviru
hepat
b
c
virus
rotaviru
respiratori
syncyti
viru
enteroviru
lactoferrin
appear
effect
earli
stage
infect
act
either
block
viral
receptor
host
cell
bind
directli
viru
itselfth
molecular
mechan
involv
vari
case
rotaviru
lactoferrin
block
entri
enterocyt
mechan
independ
iron
satur
enhanc
desialyl
protein
mimick
two
tryptic
peptid
howev
involv
lactoferricin
region
molecul
superti
et
al
also
seem
case
antihepat
c
activ
peptid
ctermin
region
lactoferrin
bind
hepat
c
viru
protein
prevent
interact
host
cell
nozaki
et
al
contrast
abil
lactoferrin
inhibit
vitro
hepat
b
viru
infect
depend
upon
interact
hepatocyt
rather
viru
hara
et
al
lactoferricin
region
partli
entir
respons
abil
lactoferrin
inhibit
bind
hiv
receptor
berkhout
et
al
vast
major
studi
refer
vitro
antivir
activ
much
less
evid
antivir
role
lactoferrin
vivo
howev
lactoferrin
administ
suckl
mice
improv
surviv
rate
experiment
hantaviru
infect
murphi
et
al
protect
cytomegaloviru
infect
mice
also
report
though
appear
result
enhanc
natur
killer
nk
cell
activ
rather
direct
antivir
activ
shimizu
et
al
final
clinic
trial
bovin
lactoferrin
hepat
c
viru
infect
caus
temporari
improv
patient
okada
et
al
number
antiparasit
effect
lactoferrin
report
though
role
lactoferrin
antiparasit
molecul
remain
ill
defin
mechan
elucid
tend
parasit
specif
exampl
basic
properti
lactoferrin
respons
abil
prevent
plasmodium
bergei
invad
fibroblast
shakibaei
frevert
inhibit
thrombospondinmedi
bind
plasmodium
falciparuminfect
erythrocyt
epithelia
eda
et
al
lactoferrin
inhibit
vitro
growth
p
falciparum
kassim
et
al
pneumocysti
carinii
cirioni
et
al
latter
case
result
ironwithhold
mechan
parasit
tritrichomona
foetu
grab
et
al
treponema
pallidum
alderet
et
al
leishmania
chagasi
wilson
et
al
possess
mechan
remov
iron
lactoferrin
might
therefor
expect
enhanc
rather
inhibit
growth
antimicrobi
effect
lactoferrin
known
decad
recent
becom
appar
lactoferrin
influenc
immun
inflammatori
respons
case
antimicrobi
activ
found
result
immunomodulatori
activ
rather
direct
antimicrobi
effect
one
mechan
lactoferrin
may
exert
antiinflammatori
effect
via
bind
nontransferrin
bound
iron
inflammatori
foci
thu
render
unabl
catalyz
potenti
harm
freerad
reaction
guillen
et
al
anoth
mechan
depend
upon
previous
mention
abil
lactoferrin
bind
bacteri
lp
review
bavey
et
al
result
impair
lp
bind
solubl
surfac
monocyt
bavey
et
al
subsequ
product
mattsbybaltz
et
al
nitric
oxid
choe
lee
neutrophil
lactoferrin
inhibit
bind
lp
lselectin
subsequ
product
reactiv
oxygen
speci
bavey
et
al
also
inhibit
lpsmediat
product
endotheli
cell
elass
et
al
activ
mediat
basic
ntermin
region
lactoferrin
zhang
et
al
murin
model
endotoxemia
lactoferrin
found
effect
reduc
paramet
endotox
shock
administ
hour
lp
administr
lactoferrin
either
hour
lp
follow
develop
endotoxemia
less
effect
kruzel
et
al
oral
administ
lactoferrin
basic
ntermin
peptid
also
reduc
sever
dextran
sulfateinduc
coliti
mice
haversen
et
al
mechan
unknown
could
involv
interfer
bind
dextran
mucos
cell
result
charg
neutral
although
report
shown
lactoferrin
antiinflammatori
immunosuppress
effect
studi
show
contrari
result
immobil
solubl
lactoferrin
stimul
eosinophil
activ
thoma
et
al
suggest
lactoferrin
bound
airway
epitheli
cell
might
exacerb
asthma
though
similar
scenario
gut
might
result
enhanc
antiparasit
activ
induct
collageninduc
arthriti
mice
constitut
express
human
lactoferrin
found
develop
sever
congen
control
guillen
et
al
suggest
may
result
lactoferrin
skew
immun
respons
toward
proinflammatori
type
rather
antiinflammatori
type
respons
lactoferrin
also
report
act
transactiv
upregul
transcript
gene
son
et
al
activ
may
relat
propos
lactoferrin
act
transcript
factor
furmanski
summari
despit
extens
research
much
remain
learn
lactoferrin
thank
larg
crystallograph
studi
baker
et
al
fairli
complet
knowledg
structur
lactoferrin
ironbind
properti
increas
evid
lactoferrin
may
genuin
multifunct
protein
ironbind
releas
basic
peptid
perhap
proteolyt
activ
requir
differ
function
scenario
howev
must
rememb
mani
propos
function
lactoferrin
base
entir
vitro
studi
vivo
data
support
mani
lack
even
extens
studi
area
role
basic
ntermin
lactoferricin
peptid
still
know
peptid
actual
produc
vivo
function
signific
quantiti
hope
futur
research
focu
vivo
relev
function
base
vitro
studi
eventu
lead
clinic
evalu
lactoferrin
use
prophylact
therapeut
agent
peroxidas
activ
found
exocrin
secret
includ
milk
tear
saliva
well
vagin
fluid
tabl
activ
deriv
enzym
synthes
gland
produc
secret
contribut
also
come
polymorphonuclear
leukocyt
myeloperoxidas
mpo
possibl
eosinophil
eosinophil
peroxidas
epo
comprehens
discuss
variou
member
peroxidas
famili
beyond
scope
chapter
attent
focu
human
salivari
peroxidas
hspo
human
lactoperoxidas
hlpo
compar
purpos
bovin
lactoperoxidas
blpo
latter
enzym
studi
extens
readi
avail
high
puriti
mani
properti
common
hspo
hlpo
human
spo
protein
secret
parotid
gland
gene
hspo
clone
sequenc
kiser
et
al
sequenc
similar
except
two
nucleotid
hlpo
suggest
two
enzym
fact
product
gene
express
differ
tissu
salivari
mammari
gland
amino
acid
sequenc
hspo
display
ident
ctermin
fragment
hlpo
dull
et
al
addit
hspo
share
high
amino
acid
ident
mammalian
peroxidas
tabl
high
degre
homolog
exist
hspo
blpo
ctermin
amino
acid
show
homolog
dull
et
al
howev
hspo
fewer
cystein
methionin
isoleucin
residu
alanin
glycin
prolin
serin
residu
blpo
carbohydr
composit
differ
hspo
also
sensit
inactiv
azid
et
al
blpo
molecul
consist
singl
polypeptid
chain
one
heme
group
coval
attach
protein
via
two
ester
linkagesth
sequenc
blpo
align
human
peroxidas
reveal
follow
similar
mpo
epo
thyroid
peroxidas
blpo
probabl
ellipsoid
structur
solut
paul
ohlsson
properti
similar
small
globular
protein
infer
higher
order
structur
hspo
made
base
amino
acid
composit
solut
properti
mosaic
hydrophob
charg
group
surfac
hspo
respons
strong
affin
mani
differ
kind
surfac
pruitt
adamson
pruitt
et
al
sinc
absorb
hspo
retain
enzym
activ
attach
surfac
block
donor
access
heme
group
thu
surfacebind
site
heme
group
immedi
proxim
prepar
blpo
bovin
milk
heterogen
paul
ohlsson
major
fraction
blpo
consist
singl
polypeptid
chain
kda
subfract
lower
molecular
mass
deriv
loss
carbohydr
group
deamid
asparagin
glutamin
residu
hspo
human
saliva
also
heterogen
et
al
least
three
major
form
kda
report
human
milk
contain
least
two
peroxidas
hlpo
mpo
deriv
milk
leukocyt
rel
amount
vari
wide
sampl
sampl
depend
stage
lactationth
properti
hlpo
similar
hspo
peroxidas
protect
mucos
surfac
microorgan
catalyz
peroxid
halid
cl
br
pseudohalid
thiocyan
ion
scn
gener
reactiv
product
potent
antimicrobi
properti
mpo
epo
catalyz
peroxid
cl
br
scn
blpo
hlpo
hspo
catalyz
peroxid
cl
absenc
halid
scn
peroxidas
behav
catalas
degrad
h
water
oxygen
catalas
peroxidas
activ
enzym
also
protect
mucos
surfac
prevent
accumul
toxic
product
oxygen
reduct
peroxidas
kinet
reaction
mechan
complex
review
see
pruitt
kamau
product
reaction
mechan
depend
particular
enzym
particular
donor
rel
concentr
enzym
h
donor
ph
temperatur
mucos
defens
mechan
signific
peroxidas
reaction
relat
catalas
activ
thiocyan
oxid
hspo
mpo
hlpo
although
actual
reaction
complex
includ
multipl
intermedi
net
reaction
peroxid
thiocyan
physiolog
concentr
peroxid
scn
occur
via
compound
oxid
equival
peroxid
transfer
heme
group
hypothiocyanit
ion
oscn
equilibrium
conjug
acid
hoscn
pk
net
peroxid
reaction
may
appar
state
dynam
equilibrium
vivo
pruitt
et
al
minim
concentr
h
maxim
concentr
hoscn
oscn
set
reaction
consum
toxic
h
gener
product
harmless
host
reaction
protect
bacteria
h
toxic
adamson
carlsson
howev
hoscn
oscn
inhibit
growth
metabol
mani
speci
bacteria
review
see
pruitt
reiter
major
limit
factor
scn
peroxid
human
saliva
avail
h
shown
experi
addit
h
human
saliva
vivo
et
al
vitro
tenovuo
et
al
result
increas
concentr
hoscn
oscn
howev
concentr
scn
mm
may
also
limit
human
milk
concentr
scn
usual
level
low
peroxidas
concentr
human
milk
also
may
limit
factor
pruitt
kamau
thiocyan
ion
critic
compon
hspo
system
secret
salivari
mammari
lacrim
gastric
gland
origin
sever
sourc
salivari
scn
concentr
vari
consider
depend
exampl
diet
smoke
habit
howev
major
sourc
scn
detoxif
cn
primarili
liver
enzym
thiosulfatecyanid
sulfurtransferas
catalyz
transfer
sulfur
atom
thiosulf
cn
yield
nontox
scn
normal
plasma
level
scn
secret
fluid
contain
hspo
hlpo
blpo
level
much
higher
thiocyan
found
parotid
submandibular
whole
saliva
well
gingiv
crevicular
dental
plaqu
fluid
tenovuo
milk
pruitt
kamau
averag
concentr
scn
saliva
nonsmok
report
rang
mm
mm
wherea
report
rang
smoker
vari
mm
mm
tenovuo
human
milk
mean
valu
mm
mm
report
larg
variat
sampl
sampl
pruitt
kamau
thu
scn
concentr
plasma
salivari
gland
human
anim
appar
activ
transport
tenovuo
et
al
show
concentr
scn
whole
saliva
rise
initi
stimul
gradual
declin
howev
instanc
secret
rate
scn
concentr
scn
secret
flow
rate
whole
stimul
saliva
drop
unstimul
saliva
indic
scn
transport
system
abl
maintain
scn
level
despit
increas
dilut
result
stimul
thu
activ
transport
scn
may
increas
stimul
activ
transport
scn
saliva
may
also
provid
recycl
mechan
import
ion
saliva
swallow
continu
scn
would
reabsorb
blood
gastrointestin
uptak
concentr
salivari
gland
mpo
catalyz
oxid
cl
h
form
water
highli
reactiv
oxid
agent
hypochlorit
ion
ocl
activ
latent
collagenas
elastas
gelatinas
cathepsin
present
leukocyt
inactiv
circul
proteas
inhibitor
caus
tissu
injuri
weiss
cytocid
hypohal
acid
oxid
also
produc
epo
oxid
halid
br
cl
absenc
scn
although
hypohal
acid
oxid
mediat
kill
bacteria
extracellular
destruct
invad
helminth
parasit
gleich
adolphson
oxid
also
extrem
tissu
destruct
slungaard
mahoney
howev
scn
shown
prefer
substrat
mpo
epo
although
present
serum
significantli
lower
concentr
halid
thoma
fishman
slungaard
mahoney
prefer
scn
result
gener
hoscn
oscn
nontox
human
cell
tissu
et
al
slungaard
mahoney
tenovuo
larjava
thoma
fishman
thu
scn
protect
varieti
tissu
damag
could
occur
result
peroxidasecatalyz
oxid
cl
br
exampl
reaction
accompani
respiratori
burst
leukocyt
oxid
cl
ion
mpo
may
gener
toxic
product
weiss
peroxidasescn
system
antibacteri
effect
mani
streptococcu
speci
pruitt
reiter
periodontitisassoci
bacteria
tenovuo
courtoi
et
al
ihalin
et
al
anaerob
mucos
pathogen
tabl
streptococci
system
inhibit
glucos
incorpor
glycolysi
acid
product
cariogen
bacteria
pruitt
reiter
lenanderlumikari
loimaranta
also
affect
cytoplasm
membran
inhibit
variou
membran
oxidas
reductas
respiratori
chain
format
electrochem
proton
gradient
e
coli
reduct
bacteri
acid
product
peroxidas
system
enhanc
presenc
siga
tenovuo
et
al
effect
depend
specif
antibodi
although
peroxidasemedi
effect
gramposit
bacteria
mere
bacteriostat
neutral
ph
gramneg
bacteria
e
coli
p
gingivali
kill
fadel
courtoi
shin
et
al
addit
bacteri
speci
yeast
mani
virus
tabl
sensit
peroxidasescn
system
pourtoi
et
al
mikola
et
al
mimick
salivari
antibacteri
capac
achiev
commerci
product
ad
blpo
system
lactoferrin
lysozym
variou
oral
health
care
product
target
patient
hyposaliv
xerostomia
product
blpo
supplement
kscn
necessari
h
gener
mouth
glucoseglucos
oxidas
system
origin
rational
elev
vivo
concentr
hoscnoscn
bactericid
level
although
inde
appear
increas
salivari
oscn
concentr
clinic
evid
enhanc
antimicrobi
activ
human
saliva
vivo
tenovuo
interestingli
recent
observ
indic
antimicrobi
activ
mucos
pathogen
greatli
enhanc
blpo
replac
horseradish
peroxidas
oxid
scn
ph
iodid
use
oxidiz
agent
instead
scn
ihalin
et
al
addit
major
better
known
innat
factor
describ
previous
numer
antimicrobi
agent
wide
varieti
found
differ
secret
especi
present
saliva
subject
intens
investig
molecular
level
recent
year
inorgan
organ
acid
present
mani
secret
known
antimicrobi
properti
exampl
neutral
stomach
hydrochlor
acid
result
reduct
infecti
dose
salmonella
typhi
mim
et
al
lactic
acid
larg
produc
lactobacilli
believ
substanti
import
mainten
vagin
health
inhibit
growth
organ
involv
bacteri
vaginosi
well
hiv
see
chapter
human
milk
contain
larg
number
oligosaccharid
apart
lactos
present
concentr
gl
excret
intact
infant
urin
thought
signific
nutrit
valu
sever
found
resembl
carbohydr
structur
present
bacteri
cell
wall
exampl
group
b
streptococci
pritchard
et
al
give
rise
specul
might
abl
interfer
bacteri
adher
host
cell
report
case
adher
e
coli
uroepitheli
cell
coppa
et
al
sialyllactos
fucosyl
pruitt
reiter
tenovuo
lenanderlumikari
loimaranta
milk
oligosaccharid
also
found
inhibit
cholera
toxin
heatstabl
enterotoxin
e
coli
idota
et
al
newburg
et
al
presum
interf
bind
toxin
carbohydr
receptor
salivari
mucin
report
form
heterotyp
complex
variou
protein
includ
lysozym
well
siga
therebi
enhanc
bind
agglutin
properti
biesbrock
et
al
iontcheva
et
al
salivari
agglutinin
glycoprotein
occur
parotid
secret
bind
variou
oral
streptococci
rundegren
found
ident
scaveng
receptor
present
bronchoalveolar
fluid
also
bind
lung
surfact
protein
ligtenberg
et
al
collectin
constitut
famili
lectin
possess
triplehel
collagenlik
domain
well
ctermin
ca
depend
lectin
domain
holmskov
et
al
best
known
serum
mannosebind
lectin
mbla
initi
complement
activ
bind
iga
roo
et
al
bovin
conglutinin
interact
complement
breakdown
product
abl
neutral
influenza
viru
hartshorn
et
al
livertyp
mannosebind
lectin
mblc
recent
identifi
liver
also
small
intestin
presum
play
role
mucos
defens
uemura
et
al
spa
spd
close
relat
conglutinin
occur
lung
surfact
synthes
type
ii
alveolar
cell
hopp
reid
spa
possibl
spd
bind
bacteria
virus
via
carbohydr
group
promot
phagocytosi
alveolar
macrophag
possibl
interact
relat
receptor
nepomuceno
et
al
larg
number
peptid
small
protein
antimicrobi
activ
share
gener
characterist
high
content
arginin
lysin
residu
confer
high
isoelectr
point
describ
wide
varieti
secret
tissu
includ
defensin
cathelicidin
intestin
cryptdin
well
magainin
amphibian
skin
insect
cecropin
discuss
chapter
note
previous
antibacteri
effect
lysozym
probabl
cation
natur
nuclear
histon
bactericid
properti
vitro
whether
signific
vivo
debat
angiogenin
origin
discov
protein
human
carcinoma
cell
abil
stimul
vasculogenesi
chorioallanto
membran
chick
known
compris
famili
four
protein
variou
mammalian
speci
howev
sever
observ
suggest
angiogenin
releas
liver
circul
acutephas
respons
may
involv
defens
infect
found
express
intestin
paneth
cell
mice
especi
stimul
gut
commens
bacteria
bacteroid
thetaiotaomicron
hooper
et
al
protein
member
ribonucleas
famili
secret
along
lysozym
paneth
cell
granul
give
rise
crypt
concentr
exceed
mm
display
potent
bactericid
activ
gramposit
enterococcu
faecali
listeria
monocytogen
pneumonia
yeast
candida
albican
concentr
low
angiogenin
demonstr
differ
antimicrobi
activ
vitro
thu
propos
angiogenin
constitut
new
famili
peptid
involv
innat
defens
prolinerich
protein
prp
larg
famili
salivari
protein
produc
parotid
submandibular
gland
prp
constitut
nearli
total
protein
human
saliva
prolin
account
amino
acid
bennick
prp
subdivid
three
group
acid
basic
glycosyl
encod
six
gene
character
variabl
number
tandem
repeat
basepair
azen
maeda
basic
glycosyl
prp
encod
four
gene
acid
two
gene
prp
synthes
precursor
protein
amino
acid
mani
cleav
secret
give
rise
larg
number
prp
saliva
identifi
variabl
prp
aris
differenti
rna
process
acid
prp
phenotyp
product
allel
gene
interestingli
submandibular
gland
express
acid
type
function
role
acid
prp
includ
bind
hydroxyapatit
thu
becom
part
acquir
enamel
pellicl
teeth
bind
calcium
ion
inhibit
crystal
growth
calcium
phosphat
supersatur
solut
therebi
help
maintain
tooth
integr
review
lamkin
oppenheim
function
accomplish
aminotermin
region
molecul
highli
acid
carboxyltermin
domain
acid
prp
implic
bacteri
bind
especi
type
fimbria
actinomyc
viscosu
bind
may
facilit
format
dental
plaqu
happen
prp
adsorb
hydroxyapatit
free
solubl
protein
bound
protein
undergo
conform
chang
carboxytermin
molecul
expos
receptor
bacteri
attach
socal
cryptitop
hidden
epitop
gibbon
provid
effici
mean
viscosu
bind
teeth
without
clear
oral
caviti
hydroxyapatitebound
acid
prp
also
bind
mutan
streptococcu
gordonii
mutan
bind
strongli
larger
prp
case
gordonii
bind
local
two
carboxyltermin
residu
review
lamkin
oppenheim
acid
prp
tooth
surfac
degrad
peptid
potenti
defens
properti
dental
plaqu
proteolysi
madapallimattan
bennick
recent
studi
show
possibl
releas
pentapeptid
antimicrobi
properti
acid
prp
proteolyt
activ
commens
streptococcu
actinomyc
spp
synthet
pentapeptid
desorb
bound
bacteria
counteract
sucroseinduc
decreas
dental
plaqu
ph
vitro
li
et
al
prp
submandibularsublingu
saliva
also
found
inhibit
herp
simplex
viru
replic
gu
et
al
identifi
receptor
c
albican
osullivan
et
al
anoth
acid
prp
express
human
lacrim
gland
dickinson
thiess
share
homolog
salivari
appear
express
also
salivari
gland
function
unknown
although
thought
interact
ocular
microb
contrast
function
basic
prp
express
parotid
saliva
well
character
effect
form
insolubl
complex
condens
tannin
tannic
acid
bind
acid
glycosyl
prp
baxter
et
al
lu
bennick
find
suggest
prp
play
role
protect
harm
dietari
tannin
review
bennick
parotid
salivari
basic
prolinerich
protein
shown
inhibit
infect
independ
secretori
leukocyt
proteas
inhibitor
thrombospondin
robinowitch
et
al
postul
mechan
involv
virushost
cell
interact
possibl
bind
basic
prolinerich
protein
coat
glycosyl
prp
also
bind
microorgan
depend
presenc
tooth
pellicl
saliva
facilit
adher
bacteria
oral
surfac
clearanc
mouth
respect
review
bennick
gene
encod
human
salivari
mucin
clone
evid
least
two
type
structur
function
distinct
salivari
mucin
highmolecularweight
kda
lowmolecular
weight
kda
mucin
glycoprotein
respect
levin
et
al
heavili
oglycosyl
molecul
respect
tandem
repeat
apoprotein
core
produc
submandibularsublingu
well
minor
salivari
gland
assum
exist
monom
although
form
dimer
tetram
vitro
mehrotra
et
al
wherea
oligom
compos
multipl
disulfidelink
subunit
salivari
mucin
part
viscoelast
mucu
contribut
format
protect
film
soft
hard
tissu
oral
caviti
play
bigger
role
mucos
enamel
surfac
coat
involv
modul
microbi
flora
review
levin
tabak
tabak
amphifunct
molecul
levin
regul
oral
microbiota
facilit
attach
prolifer
microorgan
bind
clearanc
other
depend
upon
intraor
locat
salivari
mucin
interact
respiratori
eg
p
aeruginosa
cariogen
eg
mutan
periodont
pathogen
eg
p
gingivali
opportunist
yeast
c
albican
even
virus
review
schenkel
et
al
highmolecularweight
glycoprotein
probabl
mucin
complex
human
saliva
inhibit
mutan
glucosyltransferas
may
therebi
contribut
control
mutan
colon
oral
caviti
jespersgaard
et
al
molecular
clone
gene
encod
salivari
mucin
reveal
encod
gene
bobek
et
al
protein
core
compos
amino
acid
residu
contain
six
tandem
repeat
amino
acid
mixtur
least
two
mucin
encod
respiratori
mucin
major
compon
code
protein
amino
acid
contain
tandem
repeat
consist
four
superrepeat
residu
desseyn
et
al
classifi
gelform
mucin
membranebound
mucin
largest
mucin
identifi
date
protect
oral
epitheli
surfac
like
involv
gelform
membranebound
mucin
express
salivari
gland
epithelia
membranebound
mucin
constitut
protect
mucin
barrier
layer
prevent
access
bacteria
fungi
virus
may
form
scaffold
upon
assembl
form
multim
recent
demonstr
peptid
possibl
gener
vivo
proteolyt
enzym
directli
kill
bacteria
fungi
vitro
make
multifacet
critic
compon
oral
defens
system
satyanarayana
et
al
liu
et
al
bobek
situ
peptid
deriv
nterminu
span
residu
fig
possess
antifung
activ
compar
exceed
antifung
activ
histatin
satyanarayana
et
al
bobek
situ
peptid
effect
wildtyp
azoleresist
amphotericin
bresist
c
albican
cryptococcu
neoforman
respect
candida
glabrata
candida
krusei
saccharomyc
cerevisia
comparison
histatin
fungicid
activ
c
albican
seem
independ
fungal
metabol
activ
although
cross
fungal
cell
membran
accumul
insid
cell
mitochondria
target
either
c
albican
c
neoforman
also
show
potent
bactericid
activ
mutan
gordonii
p
gingivali
actinomycetemcomitan
p
aeruginosa
e
coli
bobek
situ
peptid
shown
bind
kill
oral
streptococci
actinomycetemcomitan
liu
et
al
liu
et
al
although
peptid
potent
broad
rang
microorgan
vitro
remain
determin
effect
vivo
thu
far
result
two
preliminari
studi
indic
peptid
well
histatin
effect
c
albican
anim
model
candidiasi
intini
et
al
unpublish
result
histatin
famili
least
small
histidinerich
cation
peptid
secret
human
saliva
salivari
gland
signific
vitro
antimicrobi
activ
especi
fungi
candida
oppenheim
et
al
histatin
fig
abund
credit
anticandid
activ
histatin
effect
xu
et
al
histatin
encod
gene
respect
sabatini
et
al
histatin
proteolyt
product
histatin
histatin
believ
aris
histatin
proteolyt
process
besid
kill
wildtyp
c
albican
histatin
found
effect
vitro
kill
candida
speci
resist
commonli
use
antimycot
fluconazol
amphotericin
b
tsai
bobek
helmerhorst
et
al
well
c
neoforman
tsai
bobek
aspergillu
fumigatu
helmerhorst
et
al
histatin
analogu
exhibit
synergest
effect
amphotericin
b
aspergillu
candida
cryptococcu
strain
amphotericin
bresist
c
albican
laboratori
mutant
va
nt
hof
et
al
despit
numer
studi
mechan
histatin
antifung
action
remain
unclear
earlier
studi
show
histatin
unlik
cation
amphipath
antimicrobi
peptid
exert
antifung
action
pore
format
alter
membran
permeabl
lead
cell
lysi
rather
act
multistep
mechan
histatin
intern
c
albican
possibl
histatinbind
protein
edgerton
et
al
target
energ
mitochondria
helmerhorst
et
al
kill
c
albican
accompani
releas
intracellular
potassium
ion
xu
et
al
intracellular
atp
koshlukova
et
al
histatin
inhibit
respir
induc
format
reactiv
oxygen
speci
c
albican
cell
well
isol
mitochondria
lead
cell
death
histatin
toxic
c
albican
concomit
decreas
cellular
volum
close
coupl
loss
intracellular
atp
cell
cycl
arrest
baev
et
al
growthinhibitori
activ
bactericid
effect
histatin
first
shown
mutan
histatin
inhibit
hemagglutin
p
gingivali
murakami
et
al
therebi
inhibit
colon
bacteria
inhibit
coaggreg
p
gingivali
streptococcu
miti
murakami
et
al
histatin
also
inhibit
proteas
p
gingivali
nishikata
et
al
arggingipain
lysgingipain
well
host
matrix
metalloproteinas
gusman
et
al
histatin
peptid
span
amino
acid
previous
identifi
smallest
fragment
retain
anticandid
activ
compar
parent
compound
also
show
antibacteri
activ
p
aeruginosa
e
coli
aureu
promin
pathogen
cystic
fibrosi
cf
patient
sajjan
et
al
peptid
activ
presenc
purul
sputum
cf
patient
mirrorimag
peptid
amino
acid
configur
retain
signific
activ
presenc
sputum
thu
show
potenti
inhal
chronic
suppress
therapi
cf
patient
inhibitori
effect
histatin
leukotox
activ
actinomycetemcomitan
strongli
implic
pathogenesi
juvenil
periodont
suggest
new
biolog
function
histatin
oral
caviti
murakami
et
al
histatin
natur
antimicrobi
peptid
show
littl
toxic
toward
mammalian
cell
low
tendenc
elicit
resist
thu
great
potenti
develop
novel
class
antimicrobi
although
vivo
studi
fig
peptid
exhibit
antimicrobi
activ
number
sequenc
correspond
actual
amino
acid
posit
number
nativ
data
bobek
situ
publish
histatin
deriv
efficaci
experiment
gingiv
beagl
dog
paquett
et
al
human
clinic
trial
mickel
et
al
van
dyke
et
al
mouth
rins
formul
evalu
phase
ii
multicent
clinic
trial
van
dyke
et
suggest
safe
reduc
develop
gingiv
bleed
gingiv
plaqu
human
experiment
gingiv
histatin
also
examin
efficaci
c
albican
infect
murin
model
vulvovagin
candidiasi
rat
model
oral
candidiasi
comparison
clotrimazol
gold
standard
candidiasi
treatment
intini
et
al
unpublish
data
result
show
histatin
deliv
pluron
gel
effect
either
model
human
salivari
cystatin
belong
famili
cystatin
superfamili
deriv
common
ancestor
review
bobek
levin
member
superfamili
potent
inhibitor
cystein
proteinas
salivari
cystatin
encod
four
relat
gene
encod
cystatin
sn
sa
respect
cystatin
sn
sa
acid
protein
ident
cystatin
contain
residu
show
sequenc
homolog
salivari
cystatin
express
also
tissu
bodi
primarili
exocrin
epithelia
littl
known
function
cystatin
secret
propos
salivari
cystatin
evolv
ancestr
housekeep
gene
encod
ubiquit
express
cystatin
c
potenti
function
type
cystatin
direct
inhibit
endogen
exogen
cystein
proteinas
control
miner
tooth
surfac
antibacteri
antivir
activ
modul
immun
system
review
dickinson
result
studi
concern
salivari
cystatin
level
respect
increas
oral
inflamm
periodont
diseas
controversi
cystatin
level
report
declin
increas
chang
review
dickinson
vitro
salivari
cystatin
sn
inhibit
human
lysosom
cathepsin
b
h
l
cystatin
sa
inhibit
cathepsin
l
involv
periodont
tissu
destruct
baron
et
al
suggest
salivari
cystatin
sa
sn
involv
control
proteolyt
event
vivo
cystatin
inhibit
proteas
abl
bind
calcium
bind
rapidli
carbon
apatit
sa
sn
suggest
primari
role
oral
environ
like
involv
miner
balanc
teeth
previou
find
show
cystatin
bind
hydroxyapatit
major
compon
enamel
pellicl
review
bobek
levin
cystatin
sn
sa
also
good
inhibitor
papain
relat
enzym
plant
suggest
may
block
noxiou
effect
dietari
cystein
proteinas
protect
salivari
protein
degrad
cystatin
shown
taken
cell
interfer
viral
replic
depend
host
viral
cystein
proteinas
thu
cystatin
sn
inhibit
replic
herp
simplex
gu
et
al
weaverhiltk
bobek
effect
cystatin
c
cystatin
inhibit
replic
coronaviru
collin
grubb
cystatin
present
tear
saliva
weakli
inhibit
adenain
cystein
proteinas
adenoviru
thu
unlik
play
signific
role
inhibit
adenoviru
infect
vivo
ruzindanaumunyana
weber
mani
type
cystatin
wide
rang
effect
immun
cell
review
dickinson
list
includ
sdtype
cystatin
found
adher
human
fibroblast
cell
surfac
molecul
mainli
lead
express
releas
kato
et
al
salivari
cystatin
thu
may
regul
cytokin
network
gingiv
connect
tissu
would
also
interest
determin
whether
sdtype
cystatin
role
suppress
oral
cancer
secretori
leukocyt
proteas
inhibitor
slpi
found
highest
concentr
saliva
present
also
breast
milk
genit
secret
protein
exhibit
antimicrobi
activ
thought
play
critic
role
mucos
defens
slpi
potent
inhibitor
serin
proteinas
human
leukocyt
elastas
also
capabl
inhibit
infect
vitro
mcneeli
et
al
salivari
gland
slpi
shown
produc
acinar
epitheli
cell
parotid
submandibular
gland
travers
ductal
system
accumul
mouth
viru
local
interstiti
mononuclear
cell
within
salivari
gland
meet
slpi
oral
caviti
inhibitor
may
imped
infect
addit
target
cell
wahl
et
al
find
suggest
slpi
may
partial
respons
low
rate
oral
transmiss
slpi
block
infect
macrophag
primari
cell
concentr
occur
natur
saliva
shugar
wahl
mechan
appear
involv
block
uptak
target
cell
interact
cell
surfac
molecul
primari
receptor
rather
direct
effect
viru
replic
although
numer
studi
report
slpi
protect
cultur
mononuclear
cell
infect
inhibit
infect
human
macrophag
highli
variabl
konopka
et
al
one
studi
even
show
replic
unaffect
human
slpi
turpin
et
al
discrep
attribut
factor
variabl
macrophag
suscept
hiv
infect
qualiti
slpi
prepar
purifi
refold
slpi
protein
express
newli
clone
synthet
gene
reduc
bal
infect
differenti
human
monocyt
cell
although
commerci
avail
prepar
slpi
shine
et
al
find
warrant
thorough
reinvestig
molecular
structur
basi
antihiv
activ
slpi
sinc
elderli
individu
particularli
suscept
mucos
infect
shugar
et
al
assess
salivari
product
slpi
age
cohort
find
indic
slpi
product
also
product
lysozym
lactoferrin
total
protein
diminish
among
healthi
communitydwel
older
adult
particularli
elderli
male
impact
increas
risk
oral
diseas
advanc
age
remain
determin
infant
saliva
slpi
shown
play
import
role
reduc
transmiss
mother
child
breast
milk
mother
farquhar
et
al
besid
slpi
howev
nonimmun
endogen
inhibitor
oral
secret
includ
thrombospondin
lactoferrin
mucin
cystatin
prp
thrombospondin
aggreg
viru
block
interact
viral
entri
also
effect
physiolog
concentr
crombi
et
al
wherea
other
inhibit
hiv
supraphysiolog
concentr
addit
baron
et
al
present
evid
saliva
disrupt
hivinfect
mononuclear
leukocyt
thu
prevent
viru
multipl
celltocel
transmiss
hypoton
